Back

Decoding biological age from face photographs using deep learning

Zalay, O.; Bontempi, D.; Bitterman, D. S.; Birkbak, N.; Shyr, D.; Haugg, F.; Qian, J. M.; Roberts, H.; Perni, S.; Prudente, V.; Pai, S.; Dekker, A.; Haibe-Kains, B.; Guthier, C.; Balboni, T.; Warren, L.; Krishan, M.; Kann, B. H.; Swanton, C.; De Ruysscher, D.; Mak, R. H.; Aerts, H. J.

2023-09-12 oncology
10.1101/2023.09.12.23295132 medRxiv
Show abstract

Because humans age at different rates, a persons physical appearance may yield insights into their biological age and physiological health more reliably than their chronological age. In medicine, however, appearance is incorporated into medical judgments in a subjective and non-standardized fashion. In this study, we developed and validated FaceAge, a deep learning system to estimate biological age from easily obtainable and low-cost face photographs. FaceAge was trained on data from 58,851 healthy individuals, and clinical utility was evaluated on data from 6,196 patients with cancer diagnoses from two institutions in the United States and The Netherlands. To assess the prognostic relevance of FaceAge estimation, we performed Kaplan Meier survival analysis. To test a relevant clinical application of FaceAge, we assessed the performance of FaceAge in end-of-life patients with metastatic cancer who received palliative treatment by incorporating FaceAge into clinical prediction models. We found that, on average, cancer patients look older than their chronological age, and looking older is correlated with worse overall survival. FaceAge demonstrated significant independent prognostic performance in a range of cancer types and stages. We found that FaceAge can improve physicians survival predictions in incurable patients receiving palliative treatments, highlighting the clinical utility of the algorithm to support end-of-life decision-making. FaceAge was also significantly associated with molecular mechanisms of senescence through gene analysis, while age was not. These findings may extend to diseases beyond cancer, motivating using deep learning algorithms to translate a patients visual appearance into objective, quantitative, and clinically useful measures.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.